Activator of apoptosis harakiri
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 61–91 | Fragment:UNP Residues 61-91 Non-standard monomer:Yes (specific site not provided by mmCIF) | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 3.2;323 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient NMR sample composition:1.0-1.5 mM Hrk-TM, 200 mM D25 SDS, 5 mM D15 TCEP, 0.1 mM sodium azide, 35% v/v D3 methanol, 95% H2O/5% D2O | 95% H2O/5% D2O NMR sample composition:1.0-1.5 mM Hrk-TM, 200 mM D25 SDS, 0.1 mM sodium azide, 5 mM D15 TCEP, 35% v/v D4 methanol, 100% D2O | 100% D2O | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 2L5B | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 2L58 Solution structure of the cytosolic fragment 22-53 of Bcl-2 member Harakiri Deposited 2010-10-28 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
22–53(32 aa)
Fragment:UNP residues 22-53
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.8;303 K;Ionic strength (raw mmCIF value) 0.1;Pressure ambient
NMR sample composition
1.0-1.5 mM Hrk-22_53, 0.1 mM sodium azide, 20 mM sodium phosphate, 35% v/v d3 TFE, 100% D2O | 100% D2O
NMR sample composition
1.0-1.5 mM Hrk-22_53, 0.1 mM sodium azide, 20 mM sodium phosphate, 35% v/v d2 TFE, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided |
| 6XY4 Structural insight into sheep-pox virus mediated inhibition of apoptosis Deposited 2020-01-29 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
26–51(26 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.2 M Potassium sodium tartrate tetrahydrate, 0.1 M Bis-Tris propane pH 6.5, 20% w/vPEG 3350
|
Resolution 2.05 Å R-free 0.234 |
| 7P0U ORF virus encoded Bcl-2 homolog ORFV125 in complex with Puma BH3 peptide Deposited 2021-06-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain E
26–51(26 aa)
Chain U
26–51(26 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 3 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Bis-Tris propane pH 8.5, 20% PEG 3350
|
Resolution 1.99 Å R-free 0.274 |
| 7P0U ORF virus encoded Bcl-2 homolog ORFV125 in complex with Puma BH3 peptide Deposited 2021-06-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain C
26–51(26 aa)
Chain G
26–51(26 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 2 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Bis-Tris propane pH 8.5, 20% PEG 3350
|
Resolution 1.99 Å R-free 0.274 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
27–50(24 aa)
Chain F
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain D
27–50(24 aa)
Chain H
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 7 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain L
27–50(24 aa)
Chain M
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 8 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain L
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LGU Crystal structure of Bcl-xL in complex with stapled HRK peptide Deposited 2025-01-10 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 9 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain M
27–50(24 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3,350 (w/v)
|
Resolution 2.97 Å R-free 0.303 |
| 9LI8 Crystal structure of Bcl-xL in complex with HRK BH3 peptide Deposited 2025-01-13 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
27–51(25 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5 and 25% w/v Polyethylene glycol 3350.
|
Resolution 2.32 Å R-free 0.264 |
| 9UGP Crystal structure of MCL-1 in complex with HRK BH3 Deposited 2025-04-13 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
27–51(25 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;0.1 M BIS-TRIS pH 6.5, 25%(w/v) polyethylene glycol monomethyl ether 2000
|
Resolution 1.39 Å R-free 0.197 |
6 other PDB entries and 15 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | HRK_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–31; UniProt 61–91 |